Group 6 Copy 52
-2
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Saving the most endangered seabird in the Americas

    Seven years of intense field monitoring and automated recordings, showed us which factors negatively impact...

    A non-invasive way to track the fluffy yellow-bellied gliders of North Queensland, Australia

    The Yellow-bellied glider (YBG) is a unique animal that glides between trees of woodlands in North-eastern...

    Backer Badge Funded

    A biology project funded by 47 people